Kym Baker, General Manager, Pharma Services at Thermo Fisher Scientific, discusses how the Pharma Services group is helping biotech innovators developing personalized and precision biologics bring their therapeutics to life from early discovery to commercialization. By integrating their CDMO and CRO services and investing in highly advanced facilities, the Pharma Services group can offer robust and agile development services while expertly guiding their clients through each milestone in the drug development journey.
